Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

NCT02119468

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

COVID-19 Infection and Multiple Myeloma

NCT04492371

Conditions
Blood Protein Disorders, COVID-19, Cardiovascular Diseases, +26 more
Locations
  • General Hopspital Vienna/Medical University Vienna, Austria
  • UCL Saint-Luc Brussels, Belgium
  • University Hospital Ostrava Ostrava, Czechia
  • University Hospital Würzburg Würzburg, Germany
View Trial Details
Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma

NCT00019097

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations
  • Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Medicine Branch Bethesda, Maryland, United States
View Trial Details
Completed

Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma

NCT04671251

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • James R. Berenson, MD., Inc. West Hollywood, California, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Completed

Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma

NCT02056756

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Universitätsklinikum Schleswig-Holstein (UKSH) - Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine Kiel, Germany
  • Fondazione EMN Italy Onlus Torino, TO, Italy
  • Divisione di Ematologia A.O.U. Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi di Ancona Ancona, Italy
View Trial Details

Related conditions